. . . . . . . . "Abolishes interaction with CSK and impairs inhibition of NF-AT activation." . "169"^^ . . "169"^^ . . "Mutagenesis site occurs in NX_Q9Y3P8-1 at amino acids 169 - 169." . . . . . "neXtProt gold" . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "1" . . .